TY - JOUR T1 - Does a lung cancer screening programme promote smoking cessation? JF - Thorax JO - Thorax SP - 870 LP - 871 DO - 10.1136/thoraxjnl-2017-210621 VL - 72 IS - 10 AU - Filippo Lococo AU - Giuseppe Cardillo AU - Giulia Veronesi Y1 - 2017/10/01 UR - http://thorax.bmj.com/content/72/10/870.abstract N2 - Lung cancer is a preventable form of cancer with approximately 90% of cases attributable to cumulative tobacco exposure.1 Smoking cessation and early detection of lung cancer remain critical goals for lung cancer prevention and control. Indeed, the health benefits of smoking cessation reach well beyond reducing the risk of lung cancer,2 resulting in an overall reduction of tobacco-related mortality. Unfortunately, smoking cessation delivery and patient adherence is still a major challenge.While there is a body of evidence supporting smoking cessation (primary prevention) and early detection of lung cancer (secondary prevention) to decrease lung cancer mortality, data on the effectiveness and interaction between smoking cessation and lung cancer screening are still sparse and inconsistent.3–6 The administration of a rigorous smoking cessation intervention (based on the combination of counselling and drug treatment) to a lung cancer screening population may lead to high smoking cessation rates (up to 30%3).Published in Thorax, the UK Lung Cancer Screening (UKLS) trial group report the effect of low-dose CT screening on smoking cessation.7 The UKLS trial assessed the feasibility, cost-effectiveness and psychosocial impact of lung cancer screening using a single low-dose CT screen versus no screening in a UK high-risk population. The authors have investigated the behavioural effect of trial participation on smoking cessation in … ER -